Learn more

SMITH-SWINTOSKY VIRGINIA L

Overview
  • Total Patents
    22
About

SMITH-SWINTOSKY VIRGINIA L has a total of 22 patent applications. Its first patent ever was published in 2006. It filed its patents most often in United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and foods and drinks are WUHAN UNITED PHARMACEUTICAL CO LTD, YOO SEO HONG and Prilenia Neurotherapeutics Ltd.

Patent filings in countries

World map showing SMITH-SWINTOSKY VIRGINIA Ls patent filings in countries
# Country Total Patents
#1 United States 22

Patent filings per year

Chart showing SMITH-SWINTOSKY VIRGINIA Ls patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Smith-Swintosky Virginia L 22
#2 Reitz Allen B 9
#3 Maryanoff Bruce E 2
#4 Parker Michael H 2
#5 Mccomsey David F 1

Latest patents

Publication Filing date Title
US2009247616A1 Use of benzo-fused heterocyle sulfamide derivatives for the treatment of anxiety
US2007293440A1 Co-therapy for the treatment of epilepsy and related disorders
US2007191461A1 Use of benzo-heteroaryl sulfamide derivatives for the treatment of migraine
US2007191449A1 Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Depression
US2007191453A1 Use of benzo-heteroaryl sulfamide derivatives for the treatment of substance abuse and addiction
US2007191450A1 Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Mania and Bipolar Disorder
US2007191452A1 Use of benzo-heteroaryl sulfamide derivatives for the treatment of pain
US2007191474A1 Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine
US2007191451A1 Use of benzo-heteroaryl sulfamide derivatives as neuroprotective agents
US2007191459A1 Use of Benzo-Heteroaryl Sulfamide Derivatives for Lowering Lipids and Lowering Blood Glucose Levels
US2007191460A1 Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Disease Modification / Epileptogenesis
US2007155825A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US2007155826A1 Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US2007155824A1 Use of benzo-fused heterocycle sulfamide derivatives for disease modification / epileptogenesis
US2007155827A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
US2007155823A1 Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
US2008027131A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
US2007155822A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US2007155821A1 Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels